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Abstract
Despite the importance of paediatric pneumonia as a cause of short and long-term morbidity and mortality worldwide, 
a reliable gold standard for its diagnosis remains elusive. The utility of clinical, microbiological and radiological 
diagnostic approaches varies widely within and between populations and is heavily dependent on the expertise and 
resources available in various settings. Here we review the role of radiology in the diagnosis of paediatric pneumonia. 
Chest radiographs (CXRs) are the most widely employed test, however, they are not indicated in ambulatory settings, 
cannot distinguish between viral and bacterial infections and have a limited role in the ongoing management of 
disease. A standardised definition of alveolar pneumonia on a CXR exists for epidemiological studies targeting bacterial 
pneumonias but it should not be extrapolated to clinical settings. Radiography, computed tomography and to a lesser 
extent ultrasonography and magnetic resonance imaging play an important role in complicated pneumonias but 
there are limitations that preclude their use as routine diagnostic tools. Large population-based studies are needed in 
different populations to address many of the knowledge gaps in the radiological diagnosis of pneumonia in children, 
however, the feasibility of such studies is an important barrier.
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1. Introduction
Pneumonia remains the most important cause of mortality 
and morbidity in young children globally [1,2]. In addition 
to the impact of acute disease, respiratory infections 
(especially when repeated) in young children are associated 
with long-term lung function abnormality and disease in 
adults [3]. Early diagnosis and management are critical 
to short- and long-term health outcomes with several 
clinical guidelines now available for both developing and 
developed country settings, albeit with concerns about 
the inconsistencies between these documents [4]. The 
implementation and effectiveness of the guidelines vary 
widely within and between countries and, in many regions, 
improvements are still required in the diagnosis and 
management of pneumonia at the community level [5–9].
Despite the commonality of pneumonia in children, 
disagreement remains about diagnosis in both clinical 
and research settings [9,10]. Many factors contribute to 
these differences, including: health systems resourcing, 
the number of possible causative micro-organisms, host 
and environmental factors, timing of presentation to a 
health service, expertise of the health service providers 
at various levels of the health care system, availability of 
diagnostic facilities and the absence of a true diagnostic 
gold standard [11,12]. The World Health Organization 
(WHO) clinical definition developed for the community 
setting in developing countries is based on the presence of 
cough and tachypnoea [13]. This definition was developed 
particularly with the intention of identifying children 
who had bacterial pneumonia and required antibiotics 
[14]. However, while highly sensitive, this definition lacks 
specificity. The major reason for this is the problem of 
viral infections affecting airways but not lung parenchyma 
in children with these infections [15], although many of 
these children may have co-infection particularly with 
Streptococcus pneumoniae [16]. In addition, in settings 
where there is a high prevalence of conditions with 
similar symptoms and signs like malaria and tuberculosis 
(TB), differentiating pneumonia from malaria [17,18] and 
TB (with human immunodeficiency virus) at the time 
of presentation may be difficult [18,19]. Pneumonia 
may also be masked in cases of severe diarrhoea and 
hypokalaemia [20].
In the appropriate setting (e.g. trained health care 
professionals and diagnostic services), other factors 
may be considered to improve the specificity of the 
diagnosis of pneumonia. These factors include clinical 
symptoms and signs (e.g. crackles) and objective tests 
(e.g. pulse oximetry and radiology). The microbiological 
cause is often considered diagnostic but there are 
many limitations to this assessment. Despite advances 
in identifying microorganisms using highly sensitive 
molecular techniques, ascribing causation is problematic 
[11]. Even when the same molecular detection techniques 
for viruses are used, the site of specimen collection 
influences results [21]. The ideal samples for determining 
aetiologic agents in bacterial pneumonia are lower airway 
specimens. It is usually neither necessary nor feasible to 
obtain either bronchoalveolar lavage (BAL) or needle lung 
aspirate specimens in acute pneumonia [11]. Thus, it is 
not surprising that the chest radiograph (CXR) has long 
been considered the ‘gold standard for the diagnosis of 
pneumonia in children’. Historically, this has been largely 
driven by the need to identify bacterial pneumonia and 
hence inform the use and choice of antibiotic therapy [9].
Here, we review the role of radiology in paediatric 
pneumonia. We predominantly discuss the use of the 
CXR for clinical and research purposes. We also review 
other diagnostic methods including lung ultrasonography 
(LUS) and briefly discuss computed tomography (CT) and 
magnetic resonance imaging (MRI).
2. Chest Radiograph (CXR)
Although, the CXR is the most widely used diagnostic 
imaging tool for paediatric pneumonia, its use in the clinical 
context is controversial with recent guidelines advocating 
that CXRs for the diagnosis of pneumonia in the community 
setting are unwarranted [22,23] (further discussed below). 
Nevertheless, here we review the various aspects of CXRs 
related to the diagnosis of childhood pneumonia.
2.1 Patterns of CXR abnormalities
There is a spectrum of radiological appearances that are 
consistent with the clinical and pathological diagnosis 
of pneumonia, ranging from complicated pneumonia 
(e.g. pneumonia with empyema and necrotising 
pneumonia), simple or uncomplicated pneumonia (e.g. 
lobar consolidation) to mild interstitial changes [24]. The 
characteristics of childhood pneumonia on CXRs generally 
assume a pattern approach based on pathologic and 
radiologic characteristics [25].
Lobar pneumonia is usually considered to be associated 
with specific bacterial infections such as Haemophilus 
influenzae type b (Hib), S. pneumoniae and Klebsiella 
pneumoniae [25,26]. Features on CXRs are a non-
segmental, homogenous consolidation predominantly 
involving one lobe with air bronchograms (large bronchi 
remain patent and air-filled in contrast to the adjacent 
non-aerated lung) [25] (Figure 1). Multilobar pneumonia 
can occur with a number of different bacteria and is 
associated with more severe disease [27,28].
Bronchopneumonia is thought to be usually associated with 
infections due to gram-negative bacteria, Staphylococcus 
aureus and some fungi [25]. The radiological appearance 
of bronchopneumonia varies depending on the severity 
of disease. Mild disease can manifest as peribronchial 
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thickening and poorly defined air-space opacities; 
inhomogeneous patchy areas of consolidation involving 
several lobes reflect more severe disease. When confluent, 
bronchopneumonia may resemble lobar pneumonia [25].
Interstitial pneumonia (Figure 2) is typically associated 
with viral infections such as influenza virus and respiratory 
syncytial virus (RSV) [29–31]. Few pathogens are associated 
with characteristic CXR abnormalities. Pneumocystis 
jirovecii is characterised by oedema and cellular infiltrates 
predominantly involving the interstitial tissue of the 
alveolar septa and surrounding small airways and vessels 
[25]. A reticular or reticulonodular pattern and septal lines 
(Kerley B lines) may be seen in P. jirovecii infections [32]. 
Ground glass opacities and multifocal consolidation are 
associated with severe disease and have been commonly 
observed in children with severe pandemic influenza 
infections [33,34].
Lung complications of pneumonia include empyema and, 
less commonly, pulmonary abscess and necrotising lung. 
Empyema is defined as intrapleural pus or a moderate 
to large exudative parapneumonic effusion which can 
progress to being loculated, with further development of 
a fibrinous peel [35]. The CXR cannot diagnose empyema, 
only the presence of parapneumonic fluid [36]. Loculated 
effusions may be difficult to distinguish from a peripheral 
lung abscess [36]. Lung abscesses manifest radiologically 
as cavities that may be isolated or occur within areas 
of consolidation [25]. Necrotising pneumonias initially 
appear as small lucencies within an area of consolidation, 
progressing to larger, fluid filled cavities [25]. The CXR 
will reveal the presence of larger cavities and abscesses, 
although minor changes may only be visible on CT [37]. 
In complicated pneumonia, CTs will reveal abnormalities 
not detected on CXRs [38].
2.2 Limitations of CXR patterns
Other than for complicated pneumonia, there are 
limitations to this pattern approach, particularly at an 
individual level in the clinical setting where host factors 
such as age, comorbidities and immunologic status can 
modify the radiologic manifestations of pneumonia. In 
some settings there is wide variation in the use of CXRs 
in emergency departments (EDs) but no corresponding 
association with the proportion of children diagnosed with 
pneumonia [39]. The utility of clinical signs and symptoms 
present at the time of CXR to predict a radiological 
diagnosis of pneumonia, particularly in non-severe 
cases, varies across studies [18,40–45]. In addition, the 
interpretation of CXR findings is dependent on the quality 
of the film and the expertise of the reader, with several 
studies demonstrating varying degrees of concordance 
between clinicians [46–49], between clinicians and 
radiologists [48,50,51] and between radiologists [44,52]. 
Despite the frequency of use of CXRs, there is limited 
evidence to support its routine use in distinguishing 
between viral and bacterial infections and its ongoing use 
in clinical management once a diagnosis of pneumonia has 
been made.
2.3 Distinguishing between viral and bacterial infections
Differentiating between viral and bacterial pneumonia 
continues to be a major clinical challenge, whether it 
be based on clinical findings, diagnostic tests or both 
[12,53]. Comparable, well-designed studies that have 
used credible reference standards such as lung aspiration 
or comprehensive panels of laboratory investigations 
Figure 1: Chest radiograph showing right lower lobe pneumonia Figure 2: Chest radiograph showing interstitial infiltrates
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to establish the viral or bacterial origin of radiologically 
diagnosed pneumonia are limited in number. This is 
further compounded by the increasing description of 
multi-organism infection or detection for a single clinical 
episode with the use of molecular diagnostic methods 
such as polymerase chain reaction. Increasingly, viral-viral, 
viral-bacterial and bacterial-bacterial interactions in the 
pathogenesis of respiratory infections are recognised with 
in-vitro and in-vivo animal [54] and human studies [55,56]. 
Thus, although viruses may initiate the respiratory infection, 
secondary bacterial infection may occur and simply 
identifying a virus at presentation (leading to antibiotics 
being with-held) may not indicate the sole aetiology of the 
child’s acute clinical presentation. This is exemplified on a 
large-scale in previous influenza epidemics where deaths 
were caused by secondary bacterial pneumonia rather 
than the influenza infection [16,57].
A systematic review of studies published between 1975 
and 1999 that examined the radiological differentiation 
between bacterial and viral lower respiratory infection 
of children less than 18 years of age concluded that the 
degree of accuracy of the CXR was not clinically useful 
[58]. Only five studies met the inclusion criteria for this 
review. Over a decade later, little has changed [12,59]. The 
addition of other diagnostic markers such as cross-reactive 
protein (CRP), serum procalcitonin and interleukin-6 
concentrations does not substantially improve aetiological 
differentiation [60–62].
The relative contribution of bacteria to lobar consolidation 
and the spectrum of CXR changes representative of severe 
pneumonia [24,25] varies considerably. Studies using lung 
aspirates reported bacterial causes between 28% and 82% 
of lobar or bronchopneumonia, with between 1% and 54% 
of these being S. pneumoniae [26].
The contribution of bacteria to interstitial infiltrates on 
CXRs is less certain. Overall, the precision of the term 
“infiltrate” as a diagnostic predictor in clinical settings is 
low [63]. In one study, 54% of 151 physicians surveyed 
thought infiltrate could mean any of six or more different 
pathophysiologic conditions, including nonspecific 
pneumonia, interstitial pneumonia, viral pneumonia, 
consolidation, or nonspecific interstitial process [63]. A 
prospective Finnish study using multiple bacteriological 
and virological methods to obtain a diagnosis reported a 
50% split between viral and bacterial causes in children 
(n = 77) with interstitial infiltrates only [64].
2.4 CXR diagnosis of childhood pneumonia in the clinical 
context
The use of CXRs in the diagnosis of pneumonia should be 
limited to children with clinical signs suggesting severe 
pneumonia who require hospitalisation given there is 
no strong evidence to support its role in ambulatory 
settings even if the clinical findings in the child strongly 
indicate pneumonia [22,23]. However, it may be indicated 
in children with prolonged fever and cough, including 
children without tachypnoea and respiratory distress [22]. 
In children requiring hospitalisation, a CXR is indicated 
in the presence of signs suggesting severe pneumonia 
(hypoxia, tachypnoea, grunting, chest indrawing and/or 
crackles on auscultation), particularly in the presence of 
fever [65]. Lateral CXRs are not useful or necessary [66], 
unless confirmation of the presence of pleural fluid is 
required. A CXR beyond the initial procedure on admission 
is rarely necessary (see below).
2.4.1.CXR contribution to the management of paediatric 
pneumonia
There is limited evidence to support the role of the CXR 
in the ongoing management of paediatric pneumonia in 
the absence of immune compromise, complications and/or 
failure to improve [67], and none that demonstrate that 
it positively influences clinical outcomes [68,69]. In an 
analysis of 100,615 presentations for community-acquired 
pneumonia (CAP) to 36 paediatric EDs in the United States, 
centres that employed more diagnostic tests (e.g. CXR, 
blood culture and complete blood counts) had a higher 
odds ratio (OR) of children being hospitalised than low 
testing centres (OR 1.86, 95% CI 1.17-2.94), but there was 
no significant difference in revisit rates (OR 1.21, 95% CI 
0.97-1.51; p = 0.09) [70]. In a study of hospitalised children 
with CAP, increased utilisation of diagnostic testing was 
associated with longer lengths of stay (p = 0.036) but 
not with the probability of readmission (p = 0.225) [70]. 
However, in severe pneumonia, a CXR with ‘significant 
pathology’ (defined by WHO criteria [26]) has been 
associated with a high risk of antibiotic treatment failure 
[71], particularly penicillin compared to amoxicillin.
The CXR also has a limited role in the follow-up of children 
post-discharge unless cough persists and/or other signs 
suggest the child has not completely recovered [72,73]. 
Exceptions may include those with lobar collapse and 
recurrent pneumonia affecting the same lobe [22], or 
children with recurrent pneumonia where slow resolution 
of CXR changes in children hospitalised with pneumonia 
predicts 12-month chronic respiratory disease during the 
following 12 months [74].
2.5 CXR diagnosis of childhood pneumonia in the research 
context
Determining the burden of disease due to paediatric 
pneumonia, and evaluating interventions, has long 
been complicated by the lack of a reliable, standardised 
case definition for clinical and radiologically confirmed 
pneumonia that can be applied within and between studies. 
While CXR confirmation of pneumonia is considered the 
gold standard [75], its applicability in research has been 
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complicated by wide inter- and intra-observer variability.
The development of vaccines and associated clinical trials 
for bacterial infections due to Hib and S. pneumoniae 
highlighted the difficulties associated with the lack of a 
standardised and valid case definition. A validated case 
definition was necessary for the provision of reliable 
measurement of vaccine efficacy for pneumonia, 
particularly non-bacteraemic pneumonia. In the mid 
1990s, several research groups around the world 
met periodically with the WHO to discuss common 
methodological, design and logistic issues. By 1999, an 
objective of the group (referred to as the WHO Pneumonia 
Vaccine Trial Investigators Group) was to define the 
criteria for radiologically diagnosed pneumonia in children 
for the purposes of vaccine trial and burden of disease 
endpoints, particularly trials of pneumococcal and Hib 
conjugate vaccines. This process eventually led to the 
2001 publication of the WHO protocol, Standardization 
of interpretation of chest radiographs for the diagnosis of 
pneumonia in children [26].
The group reviewed existing data from aetiological studies 
comparing CXR changes with isolates obtained from 
lung aspirates together with data and films from burden 
of disease studies in various countries. Over several 
meetings, the group arrived at a consensus definition of 
bacterial pneumonia. For the purposes of epidemiological 
studies, radiologically diagnosed pneumonia endpoints 
were defined as:
1)  Significant pathology: this refers specifically to the presence 
of consolidation, infiltrates or effusion. If none of these are 
present then no further reading or recording is required for 
that film.
2) End-point consolidation: a dense opacity that may be a 
fluffy consolidation of a portion or  whole of a lobe or of the 
entire lung, often containing air bronchograms and sometimes 
associated with pleural effusion.1
3) Other (non-end-point) infiltrate: linear and patchy densities 
(interstitial infiltrate) in a lacy pattern involving both lungs, 
featuring peribronchial thickening and multiple areas of 
atelectasis. Lung inflation is normal to increased. It also 
includes minor patchy infiltrates that are not of sufficient 
magnitude to constitute primary end-point consolidation, and 
small areas of atelectasis which in children can be difficult to 
distinguish from consolidation.
4) Pleural effusion: this refers to the presence of fluid in the 
pleural space between the lung and chest wall. In most cases 
this will be seen at the costo-phrenic angle or as a layer of fluid 
adjacent to the lateral chest wall. This does not include fluid 
seen in the horizontal or oblique fissures. Pleural effusion is 
considered as primary end-point if it is in the lateral pleural 
space (and not just in the minor or oblique fissure) and is 
spatially associated with a pulmonary parenchymal infiltrate 
(including other infiltrate) OR if the effusion obliterates 
enough of the hemithorax to obscure an opacity [26].
The protocol requires CXRs to be collected, scanned, and 
read in a systematic way and specifies the criteria for 
assigning a diagnosis of pneumonia. Two independent 
personnel (preferably a paediatrician and a radiologist) 
read each film, with discordant diagnoses reviewed by a 
separate expert panel.
The WHO compiled a set of 222 films for ongoing 
training, standardisation, calibration and quality control. 
An evaluation of the protocol [26] using these films was 
published in 2005 [50]. The study assessed intra- and 
inter-rater agreement among a group of 20 clinicians 
and radiologists. Reference readings used as the “gold 
standard” concluded that 43% of the 208 interpretable 
films indicated the presence of primary EPC. The 
proportion that individual readers classified as EPC ranged 
from 8% to 61%. The median sensitivity and specificity for 
clinician diagnosis of EPC compared with the reference 
reading was 0.84 and 0.89, respectively; for radiologists 
it was 0.87 and 0.87, respectively (ranges for the two 
groups not reported). The median kappa indices were 
0.65 for clinicians and 0.73 for radiologists. Intra-observer 
agreement was high with a median of 88.5% (range: 76% 
to 99%) of films classified the same way on repeat testing. 
Overall a moderate level of agreement was achieved. The 
study indicated that the protocol, while imperfect could be 
implemented by study sites with the appropriate amount 
of training. A minimum standard for case ascertainment 
was available. Individual reader variability appears 
problematic; however, the protocol’s requirement for films 
to be read by two readers, with adjudication of discordant 
readings by an independent panel, is intended to minimise 
the impact this has on EPC estimates within studies.
The major questions posed by the WHO protocol [26] 
are a) how reliable is the method within and between 
researchers and various research populations, and b) 
how sensitive and specific is it for a diagnosis of bacterial 
pneumonia? While the protocol is now a major component 
of burden of disease and vaccine trial methodologies, few 
studies have reported their agreement between readers 
on the diagnosis of WHO defined consolidation on CXRs 
[43,50,76,77]; a limited number have reported the 
outcomes of calibrating readers to the WHO definition 
using their training images [51,78]. Furthermore, it 
appears there has been no minimum acceptable level 
of sensitivity, specificity or inter-observer agreement 
between readers established for these studies in either 
the training phases using the WHO set of 222 images or in 
the studies themselves [43,50,76,77].
The WHO protocol suggests sample size estimates for 
evaluating agreement be based on a kappa index of 0.8 and 
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precision of ±0.1, and that a reasonable minimum value of 
both sensitivity and specificity of 0.8 [26]. The evaluation 
of the protocol interpreted a kappa index of >0.6 for 
13/20 readers against the reference set as a reasonable 
level of agreement [50]. Fourteen of the 20 readers had 
sensitivities and specificities of ≥0.70 in identifying EPC. 
If this study is assumed to be the benchmark, then study 
sites using the protocol should be calibrated to at least 
these values.
In the retrospective review of radiographs from the 
Californian 7-valent pneumococcal conjugate vaccine  trial 
[76], readings were conducted by a paediatric radiologist 
and a paediatrician; the panel for discordant films 
consisted of two radiologists. Of 521 films classified as 
‘positive’ by either primary reader, the concordance rate 
for a positive reading by both readers was 48%. Amongst 
discordant films, the panel found 35% of reader A’s and 
46% of reader B’s films were positive. This provided a set 
of 361 films considered as the standard for positive films. 
Against this set, the sensitivity and specificity of reader A 
was 82% and 97%, respectively. The corresponding values 
for reader B were 88% and 97%, respectively. The kappa 
value for the two readers was 0.58 (95% CI 0.54-0.63).
In a burden of disease study in Chile [77], a kappa 
coefficient of 0.58 was reported for agreement between 
a paediatrician and paediatric radiologist although no 
further details were provided. In a study of non-severe 
pneumonia in Pakistan [43], pneumonia was reported in 
14% and 23% of 1,848 CRXs read independently by two 
radiologists; 23% of 371 discordant films were classified 
as positive by a third radiologist. The kappa statistic 
for the two initial readers was 0.46. A study of children 
presenting to emergency departments in Brazil with cough 
and tachypnoea in which 14.3% of films (n = 182) were 
positive reported a kappa of 0.70 (95% CI 0.56-0.83) for 
two radiologists [79]. It appears this study did not use a 
panel for discordant films.
These data suggest that agreement to date has, at best, 
been moderate and is likely to be dependent on the 
prevalence of the endpoint in different settings. They also 
clearly highlight the need for adequate training and an 
independent panel (also calibrated to the WHO definition) 
to review discordant films. Importantly, the lack of detail 
in most studies that have used the WHO protocol on the 
outcomes of calibration to the WHO definition needs to 
be addressed. Similarly, the usefulness of the protocol is 
dependent on film quality and, as such, ongoing quality 
control measures are critical [80].
A number of vaccine efficacy trials have now been 
conducted using the WHO protocol [76,81,82]. Vaccine 
trials have acted as probe studies to estimate the 
relative contribution of Hib and S. pneumoniae to lobar 
consolidation [83], and relatively consistent vaccine efficacy 
estimates ranging from 20% to 37% have been reported. 
However, eligibility criteria for entry into a vaccine trial 
limits the generalisability of their findings to the wider 
population, particularly given substantial differences in the 
epidemiology of these pneumonias within and between 
different populations. Similarly, most studies have used 
the WHO clinical definition for pneumonia as the indicator 
for the CXR and, as discussed previously above, there are 
limitations to this definition.
An Australian study used the WHO protocol to evaluate all 
CXRs taken in all hospitalisations for Indigenous children 
aged <5 years over a 10 year period, irrespective of 
inpatient diagnosis [84]. In this study, the CXR readers 
were blinded to the clinical history and to each other’s 
reading. Overall there were 24,115 hospitalised episodes 
of care for 9,492 children and 13,683 CXRs were taken 
within 3 days of admission. A CXR was obtained in 57% of 
all hospital admissions. WHO EPC was diagnosed in 11.6% 
of all episodes with CXR, and in 4.2% of these episodes 
there was no corresponding respiratory diagnosis. In 
addition, EPC has also been diagnosed in a relatively 
high proportion of cases of bronchiolitis, influenza and 
confirmed RSV infections in young infants [84,85], hence 
complicating the use of the WHO criteria in studies 
focusing on bacterial pneumonia during periods of high 
virus activity. Later studies have incorporated the use of 
CRP to improve the specificity of diagnosis, however its 
usefulness varies between populations [86–88].
2.6 Extending WHO EPC to clinical studies
While the WHO radiological protocol [26] has its 
limitations, it currently remains the only tool for 
the standardisation of the radiological diagnosis of 
pneumonia in children. However, reports of studies that 
have used the protocol in clinical settings have emerged 
[71,89]. This is of some concern given the protocol is not 
intended for use in the clinical context. That the protocol 
underestimates alveolar pneumonia in particular is known 
[41,86], and may be partially attributed to the protocol’s 
subjective measure of CXR quality [41]. An Australian 
study examined the concordance between the radiological 
diagnosis of alveolar pneumonia using the WHO criteria 
to that of a paediatric pulmonologist (also calibrated to 
the WHO criteria) in Aboriginal children hospitalised with 
pneumonia and requiring antibiotics (Figure 3) [41]. Of 
the 147 episodes analysed, WHO-EPC was significantly less 
commonly diagnosed in 40 episodes (27.2%) compared to 
the paediatric pulmonologist’s diagnosis (difference 20.4%, 
95% CI 9.6-31.2; p < 0.001). Clinical signs on admission were 
poor predictors for both the WHO and pulmonologist’s 
diagnoses; the sensitivities of clinical signs ranged from a 
high of 45% for tachypnoea to 5% for fever + tachypnoea + 
chest-indrawing. The positive predictive value (PPV) range 
was 40% to 20%, respectively. Higher PPVs were observed 
against the paediatric pulmonologist’s diagnosis compared 
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to WHO-EPC. The paediatric pulmonologist’s heightened 
focus on the appearance of the right middle and left lower 
lobes that do not meet the WHO-EPC definition given 
the effect of the heart shadows/borders was considered 
an important influence. The WHO radiological guidelines 
also have limited value in the diagnosis of non-alveolar 
pneumonia, with one study demonstrating poor agreement 
between clinicians and radiologists (kappa = 0.23). This 
disagreement was associated with overdiagnosis by 
paediatricians, potentially leading to overtreatment [90].
In the clinical setting, a PPV is of greater importance than a 
negative predictive value to ensure children are adequately 
treated; the reverse is more often important in research 
settings (particularly vaccine efficacy and effectiveness 
studies) [91]. Clinical studies need to carefully assess the 
relevance of the protocol to the study population and 
the research objectives. Similarly, the processes required 
to use the WHO definition of radiological pneumonia 
(e.g. calibration to the WHO training films and the 
use of at least two blinded readers together with an 
independent panel for discordant films) need to be 
maintained.
3. Lung ultrasonography (LUS)
The initial LUS as a diagnostic tool in paediatric pneumonia 
with the identification of sonographic air bronchograms 
within lung consolidation, was published by Weinberg 
et al [92] in 1986. However, until recent advances in 
technology lead to the availability of portable, handheld 
ultrasonography (US) machines, its use has been largely 
confined to a supplemental role in evaluating complex 
pneumonia [93].
LUS has many potential advantages in the paediatric 
setting over CXR and CT scan including low-cost and 
simplicity, as well as the fact that ultrasound incurs no 
risk of radiation damage. While LUS is best performed 
by trained sonographers, medical students, doctors and 
other health care workers at the bedside are now being 
trained in it use, albeit cautiously [94,95]. This raises the 
potential for diagnostic capabilities in rural and remote 
settings where other imaging modalities are not available. 
Hence, in many clinical settings where rapid diagnosis 
can facilitate improved clinical outcomes and potentially 
reduce antibiotic use, interest in the use of LUS for the 
diagnosis of pneumonia in children is growing [96,97].
LUSs are performed using high-resolution linear probes 
with longitudinal and transverse sections of the anterior, 
lateral and posterior chest walls obtained [98]. The anterior 
section is defined by the chest between the parasternal 
and anterior axillary lines, the lateral section is between 
the anterior and posterior axillary line, and the posterior 
area is beyond the posterior axillary line [98]. Horizontal 
artifacts, defined as A-ines, reflect acoustic impedance at 
the pleura-lung interface and vertical artifacts, defined 
as B-lines, indicate interstitial or alveolar abnormalities 
that correlate with lung interstitial fluid content [99]. LUS 
signs of pneumonia include subpleural lung consolidation, 
B-lines, pleural line abnormalities, pleural effusion and 
the presence of sonographic air bronchograms [92,100]. 
B-lines, confluent B-lines or small areas of sub-pleural 
consolidations suggest viral pneumonias [101,102].
While a review of the evidence comparing the sensitivity 
and specificity of LUS to CXR for the diagnosis of CAP 
in adults identified several studies [103], and 
addressed consensus for the ongoing development and 
implementation of its use as point of care diagnostic tool 
[103], there are limited high quality studies in children 
in a range of populations. In the largest study to date, 
Shah et al [104] compared LUS to CXR in 200 children and 
young adults (median age 3 years) presenting to an ED 
in New York with suspected CAP. Both LUS and CXR were 
performed on all children, with the reference standard 
being the attending paediatric radiologist’s reading of the 
CXR. Inter-observer agreement with respect to radiologist 
readings of CXRs was not reported. Study sonologists 
were ED physicians with varying levels of US experience 
who underwent a short training program before the study 
started. Sonologists were reportedly blinded to CXR results 
and radiologists were blinded to LUS findings. Pneumonia 
was considered present on LUS if lung consolidation 
(defined as a subpleural echo-poor or tissue-like region 
with blurred margins or wedge shaped borders) with 
sonographic air bronchograms was visualised. For the 
Note: Chest radiograph of left upper lobe pneumonia diagnosed 
by a paediatric pulmonologist in a 12 month old child hospitalised 
for pneumonia. Clinical signs of tachypnoea, chest-indrawing 
and crackles on admission. This film was classified as negative 
according to WHO radiological criteria. 
Figure 3: Example of chest radiograph discordant for the 
diagnosis of pneumonia between a paediatric pulmonologist and 
WHO radiological criteria when applied in the clinical context.
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diagnosis of pneumonia, LUS had an overall sensitivity of 
86% (95% CI 71%-94%), specificity of 89% (95% CI 83%-
93%), positive likelihood ratio of 7.8 (95% CI 5.0-12.4) and 
negative likelihood ratio of 0.2 (95% CI 0.1-0.4) [104].
Copetti et al [100] compared LUS with CXR in 79 Italian 
children aged 6 months to 16 years presenting to ED with 
suspected pneumonia. In these children, 60 children had 
positive LUS findings and 53 children had positive CXRs; 
there were no children who were CXR positive and lung 
ultrasound negative. Of the seven children who had a 
negative CXR but positive LUS, pneumonia was confirmed 
in four cases by thoracic CT and the authors reported 
the clinical course was consistent with pneumonia in the 
remaining three [100]. Neutrophil counts were elevated 
in 53 children with positive LUS and CRP counts were 
elevated in all 60 children with positive LUS.
While the studies above are promising, there are 
substantial limitations to both designs that necessitate 
caution, particularly the lack of any indication of the 
degree of agreement between radiologists with respect 
to CXR readings. Similarly, there is insufficient information 
with respect to the duration and severity of the illness at 
the time of presentation, relatively wide age ranges and 
insufficient eligibility criteria that would have excluded 
children with other important comorbidities that may 
have influenced clinical presentation and CXR findings at 
the time.
Further, anatomically the LUS would not be able to detect 
many regions of the lung using current US techniques. 
Segments that will invariably be undetectable by US are 
the medial segments of the lung distant to the chest wall 
which may be obscured by intervening aerated lung. Hence, 
there remains insufficient evidence to validly use LUS as 
both a diagnostic and management tool for uncomplicated 
paediatric pneumonia, although it does play an important 
role as a second line approach to confirm the diagnosis of 
empyema in children [96]. Furthermore, there are as yet 
no studies that have attempted to determine whether LUS 
can differentiate between viral and bacterial infections 
with sufficient specificity to inform clinical management. 
Similarly, there are no studies that have determined 
the effectiveness of LUS in the ongoing management of 
pneumonia over the course of an illness.
4. Computed Tomography (CT)
Predictably, adult studies have shown that CTs are 
significantly more sensitive than CXRs in the diagnosis 
of pneumonia [105], but the role of CT in paediatric 
pneumonia is still evolving. The use of CT in the diagnosis 
of pneumonia in children is usually limited to tertiary 
settings, predominantly in developed countries, given 
the resources required to perform the scan and the 
expertise needed to interpret the images. Even in those 
settings, the role of CT is generally confined to complicated 
pneumonias, particularly where parapneumonic effusion 
and empyema is suspected but not confirmed on CXR/LUS 
[22,106,107], in children who are immunocompromised 
[107] and to identify an underlying cause of pneumonia 
such as a foreign body [108] or sequestration [109]. CT 
may also be used to guide lung biopsy in cases where a 
specific aetiological diagnosis is required [110].
While CT is more sensitive in detecting parenchymal 
abnormalities than CXR [38,111,112], there is limited 
evidence to indicate the test alters management or that it 
can predict clinical outcomes [107,113]. There is also limited 
evidence to support the role of CT in reliably differentiating 
between viral and bacterial infections given the occurrence 
of overlapping features [114]. Other non-infectious 
conditions such as acute eosinophilic pneumonia and 
pulmonary haemorrhage can mimic bacterial pneumonia 
on CT [115]. CT also has many disadvantages in paediatrics. 
It requires sedation or anaesthesia in an uncooperative 
child and the dose of ionising radiation required is much 
higher than CXR. Radiation dose reduction is of particular 
importance in children as they are more susceptible to the 
risks of radiation [116].
5. Magnetic Resonance Imaging (MRI)
MRI of the lung provides both morphological and 
functional information and is an attractive non-radiation 
alternative in paediatrics [117]. In pulmonary infections 
involving alveolar infiltration or exudate patterns, it 
is thought that MRI can reliably depict these patterns 
and that the images are clearer than CXRs in segmental 
pneumonia and bronchopneumonia [118]. The role of MRI 
in diagnosing interstitial infections offers no advantage 
over the CXR [118]. However, access to MRI facilities 
is even more limited than that of CT. Also, a significant 
proportion of very young children will develop dorsal 
atelectasis associated with sedation during MRI and this 
may mask pathological processes [119].
Despite its potential advantages, there are limited studies 
that have investigated the role of MRI in paediatric 
pneumonia. In one small case series of 24 Turkish children 
with suspected lung infection, uncomplicated CAP was 
diagnosed in ten children [120]. Alveolar or interstitial 
parenchymal changes were detected in all acute cases 
and enlarged enhancing lymph nodes were seen in the 
hilar, mediastinal and axillary regions in the majority of 
children. In another study comparing the efficacy of chest 
MRI with fast imaging sequences to CXR in 40 children 
with pneumonia [121], all consolidation, lung necrosis/
abscess, bronchiectasis, and pleural effusion detected 
with CXRs were also detected with MRI. There was a high 
level of agreement between CXRs and MRI in detecting 
consolidation (kappa = 0.78) in children with pneumonia. 
The agreement between CXRs and MRI was moderate for 
detecting pleural effusion (kappa = 0.30). While the small 
amount of available data suggests MRI can be a reliable 
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alternative to the CXR, there remains insufficient evidence 
to support its role in determining aetiology, informing 
ongoing management or predicting clinical outcomes.
6. Conclusion
Radiology is widely used as an important, albeit imperfect, 
clinical tool in the diagnosis of paediatric pneumonia 
in some settings. However, like the many knowledge 
gaps in the management of childhood pneumonia [11], 
questions on radiology applications remain. As with 
most diagnostic approaches, its utility is dependent on 
the setting, the clinical presentation of the child, the 
experience of the clinician, radiographer and radiologist 
and the epidemiology of disease in the source population. 
The CXR is the most widely used approach but has limited 
value in mild illness, in predicting clinical outcomes and in 
differentiating between viral and bacterial infection. Other 
modalities such as LUS, CT and MRI have been proposed 
but their practical utility are currently questionable in non-
complicated disease.
In the research context, a standardised method for the 
interpretation of CXRs in studies of bacterial pneumonia 
in young children exists. While it has played an important 
role in vaccine trials, effectiveness studies and burden 
of disease research targeting S. pneumoniae and Hib, 
this tool designed for epidemiological purposes should 
not be extrapolated for clinical use [41,90]. Further, 
improvements in both the sensitivity and specificity of the 
WHO definition for radiologically confirmed pneumonia 
are needed. Considerable effort needs to be directed 
at achieving high inter- and intra-rater agreement and 
radiograph quality if it is to be a reliable definition for 
pneumonia in research.
There are considerable gaps in knowledge with respect 
to the radiological diagnosis of pneumonia in children 
[11], particularly in determining aetiology. Studies that 
have been conducted often have limited generalisability 
to other settings given variations in the epidemiology of 
disease worldwide. Large population-based studies are 
needed but are resource intensive and may be ethically 
questionable given radiation exposure, particularly in 
ambulatory settings. Advanced molecular methods 
may be an important contribution to the field, however 
improvements in the radiological diagnosis must also 
be accompanied by similar improvements in the clinical 
diagnosis of paediatric disease.
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